82147-0 |
How often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
Before age 18, how often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82147-0 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q7 |
Before age 18, how often did a parent or adult in your home ever hit, beat, kick, or physically hurt you in any way? Do not include spanking. Would you say-- |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Ordinal; Parents abusive; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82148-8 |
How often did a parent or adult in your home ever swear at you, insult you, or put you down^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
How often did a parent or adult in your home ever swear at you, insult you, or put you down--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82148-8 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q8 |
How often did a parent or adult in your home ever swear at you, insult you, or put you down? |
|
|
Adverse Childhood Experiences; Before; Finding; Findings; Ordinal; Parents insult; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82149-6 |
How often did anyone at least 5Y older than you or an adult, ever touch you sexually^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
How often did anyone at least 5 years older than you or an adult, ever touch you sexually--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82149-6 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q9 |
How often did anyone at least 5 years older than you or an adult, ever touch you sexually? |
|
|
Adult sexual touch freq; Adverse Childhood Experiences; Before; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
8215-6 |
Opiates |
PrThr |
Meconium |
Pt |
Ord |
Confirm |
|
ACTIVE |
Opiates [Presence] in Meconium by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
8215-6 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Opiates Mec Ql Cfm |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin; Illicit; LC/MS/MS; Mec; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
82150-4 |
How often did anyone at least 5Y older than you or an adult, try to make you touch sexually^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
How often did anyone at least 5 years older than you or an adult, try to make you touch sexually--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82150-4 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q10 |
How often did anyone at least 5 years older than you or an adult, try to make you touch sexually? |
|
|
Adult forced sexual touch; Adverse Childhood Experiences; Before; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82151-2 |
How often did anyone at least 5Y older than you or an adult, force you to have sex^pre 18Yo |
Find |
^Patient |
Pt |
Ord |
ACE.BRFSS |
|
ACTIVE |
How often did anyone at least 5 years older than you or an adult, force you to have sex--before 18 years old [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82151-2 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
ACE_BRFSS.Q11 |
How often did anyone at least 5 years older than you or an adult, force you to have sex? |
|
|
Adult forced sex freq; Adverse Childhood Experiences; Before; Finding; Findings; Gender; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH |
2.61 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed TIME to Pt and added CHALLENGE ^pre 18Yo to better represent questions about before patient turned 18 |
0 |
82152-0 |
BRFSS Adverse Childhood Experience Module |
- |
^Patient |
Pt |
- |
ACE.BRFSS |
|
ACTIVE |
BRFSS ACE Module [ACE.BRFSS] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.MTLHLTH |
|
82152-0 |
|
ACE.BRFSS |
|
|
Both |
|
|
|
0 |
|
|
|
|
|
|
Adverse Childhood Experiences; Behavioral Risk Factor Surveillance System (BRFSS); BRFSS ACE; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Random; SDOH; Survey; SURVEY.MTLHLTH |
2.63 |
2.56 |
|
Panel |
|
|
|
|
|
|
|
|
Changed TIME to Pt to match panel children |
0 |
82153-8 |
Total score |
Score |
^Patient |
Pt |
Qn |
ACE.BRFSS |
|
ACTIVE |
Total score [ACE.BRFSS] |
|
MAJ |
DefinitionDescription |
|
|
score |
|
|
|
|
|
|
SURVEY.MTLHLTH |
|
82153-8 |
|
ACE.BRFSS |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Adverse Childhood Experiences; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl |
2.58 |
2.56 |
|
|
|
|
|
|
|
{score} |
|
|
Changed TIME to Pt to match panel children |
0 |
82154-6 |
Genomic structural variant name |
Find |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Genomic structural variant name |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
82154-6 |
|
|
|
|
Observation |
|
|
|
0 |
Gen struct var name |
|
|
|
|
|
Finding; Findings; Gen struct var name; Genetic; Genetics; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Struct var |
2.56 |
2.56 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
82155-3 |
Genomic structural variant copy number |
Num |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Genomic structural variant copy number |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
MOLPATH |
|
82155-3 |
|
|
|
|
Observation |
|
|
|
0 |
Gen struct var copy num |
|
|
|
|
|
Cnt; Count; Gen struct var copy num; Genetic; Genetics; Molecular pathology; MOLPATH; No; Num; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Struct var |
2.73 |
2.56 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
82156-1 |
Protein intake |
MRat |
^Patient |
24H |
Qn |
Measured |
|
ACTIVE |
Protein intake 24 hour Measured |
|
ADD |
DefinitionDescription |
|
|
g/24 H |
|
|
|
|
|
|
NUTRITION&DIETETICS |
|
82156-1 |
|
Measured |
|
|
Both |
|
|
|
0 |
Protein intake 24h Measured |
|
|
|
|
|
1 day; 24 hours; 24HR; Diet; Dietetics; Mass Rate; mRate; Nutrition; PR; Prot; QNT; Quan; Quant; Quantitative |
2.56 |
2.56 |
|
|
|
|
|
|
|
g/(24.h) |
|
|
|
0 |
82157-9 |
Birth date |
Date |
Provider |
Pt |
Qn |
|
|
ACTIVE |
Birth date Provider |
|
MIN |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
ADMIN |
|
82157-9 |
|
|
|
|
Observation |
|
|
|
0 |
Birth Date Provider |
|
|
|
|
|
ADMIN; Birthdate; Date of birth; DOB; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.66 |
2.56 |
|
|
|
|
|
|
|
{mm/dd/yyyy} |
|
|
|
0 |
82158-7 |
Graduation state |
Loc |
Provider |
Pt |
Nom |
|
|
ACTIVE |
Graduation state Provider |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN.DEMOG |
|
82158-7 |
|
|
|
|
Observation |
|
|
|
0 |
Grad state Provider |
|
|
|
|
|
ADMIN; ADMIN.DEMOG; Grad state; Location; Nominal; Point in time; Random |
2.66 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82159-5 |
Respiratory pathogens DNA & RNA panel |
- |
Nph |
Pt |
- |
Non-probe.amp.tar |
|
ACTIVE |
Respiratory pathogens DNA and RNA panel - Nasopharynx by NAA with non-probe detection |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
82159-5 |
|
Non-probe.amp.tar |
|
|
Order |
|
|
|
0 |
Resp path DNA+RNA Pnl Nph NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; Random; Resp path DNA+; Resp path DNA+RNA; Resp path DNA+RNA Pnl; Resp pathogens; Respiratory; Respiratory bacteria & viruses; Respiratory bacteria & viruses DNA & RNA; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.77 |
2.56 |
|
Panel |
|
|
|
|
|
|
|
|
Changed "bacteria and viruses" in Component to "pathogens" for naming consistency across terms. |
0 |
8216-4 |
Opiates |
PrThr |
Meconium |
Pt |
Ord |
Screen |
|
ACTIVE |
Opiates [Presence] in Meconium by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
8216-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Opiates Mec Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Mec; OP; Opi; Opiate; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UniversalLabOrders |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
82160-3 |
Adenovirus DNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Adenovirus DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82160-3 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HAdV DNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82161-1 |
Human coronavirus HKU1 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human coronavirus HKU1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82161-1 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HCoV HKU1 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV HKU1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82162-9 |
Human coronavirus NL63 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human coronavirus NL63 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82162-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HCoV NL63 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV NL63; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82163-7 |
Human coronavirus 229E RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human coronavirus 229E RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82163-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HCoV 229E RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV 229E; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82164-5 |
Human coronavirus OC43 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human coronavirus OC43 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82164-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HCoV OC43 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV; HCoV OC43; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82165-2 |
Human metapneumovirus RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Human metapneumovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82165-2 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
hMPV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; hMPV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82166-0 |
Influenza virus A RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82166-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82167-8 |
Influenza virus A H1 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A H1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82167-8 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV H1 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82168-6 |
Influenza virus A H1 2009 pandemic RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A H1 2009 pandemic RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82168-6 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV H1 2009 pan RNA Nph NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H1; FLUAV H1 2009 pand; FLUV; Fowl plague; H1N1; H1N1v; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza virus A hemagglutinin H1 swine origin; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; S-OIV; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
82169-4 |
Influenza virus A H3 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus A H3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82169-4 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV H3 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV H3; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |